We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis. Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis.
Ask ADVFN Intelligence (AI)
SOUTH SAN FRANCISCO, Calif., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), today announced that on January 21, 2025, it granted stock options to purchase an...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.4 | -3.58744394619 | 11.15 | 11.4 | 10.58 | 509483 | 10.8602919 | CS |
| 4 | -2.57 | -19.2942942943 | 13.32 | 13.71 | 10.58 | 471930 | 11.58925851 | CS |
| 12 | -4.46 | -29.3228139382 | 15.21 | 15.85 | 10.58 | 541461 | 13.01733269 | CS |
| 26 | -3.29 | -23.433048433 | 14.04 | 16.1 | 10.32 | 449688 | 13.02933096 | CS |
| 52 | -7.75 | -41.8918918919 | 18.5 | 18.8 | 10.29 | 469079 | 13.22553554 | CS |
| 156 | -0.75 | -6.52173913043 | 11.5 | 36.64 | 3.965 | 645230 | 19.06033497 | CS |
| 260 | -11.75 | -52.2222222222 | 22.5 | 43.92 | 3.965 | 459969 | 19.681469 | CS |
| Symbol | Price | Vol. |
|---|---|---|
| TCTMTCTM Kids IT Education Inc | US$ 0.764 (321.87%) | 731.1M |
| NVDANVIDIA Corporation | US$ 120.07 (-3.67%) | 388.5M |
| RIMEAlgorhythm Holdings Inc | US$ 0.02565 (5.12%) | 341.8M |
| CLEUChina Liberal Education Holdings Ltd | US$ 0.1938 (30.77%) | 237.15M |
| BHATBlue Hat Interactive Entertainment Technology | US$ 0.0355 (-11.25%) | 236.44M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
